Showing results (51-60 of 187) with videos related to
Sort By:
Pageof 19
Clinical and Experimental Immunology|August 2, 2006
Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortalityJ Stebbing, M Bower, S Mandalia, et al.Postgraduate Medical Journal|May 9, 2006
A single centre cohort experience with a new once daily antiretroviral drugJ Stebbing, M Bower, P Holmes, et al.Journal of Clinical Pathology|August 1, 1992
Adenovirus infection of the large bowel in HIV positive patientsA Maddox, N Francis, J Moss, et al.International Journal of STD & AIDS|January 1, 1994
How should an AIDS diagnosis be given? The views of patientsA Pergami, J Catalan, N Hulme, et al.British Journal of Clinical Pharmacology|March 1, 1985
The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndromeM Ehsanullah, D A Lee, T Williams, et al.HIV Medicine|May 7, 2005
The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once dailyM-Y Tung, S Mandalia, M Bower, et al.Clinical and Experimental Immunology|November 25, 2003
Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormoneM R Goodier, N Imami, G Moyle, et al.AIDS (London, England)|November 5, 1999
Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcomaM Bower, P Fox, K Fife, et al.AIDS Care|April 1, 1997
Reasons given by patients for "non-progression' in HIV infectionM Troop, P Easterbrook, S Thornton, et al.Journal of Psychosomatic Research|April 1, 1996
The psychological impact on staff of caring for people with serious diseases: the case of HIV infection and oncologyJ Catalan, A Burgess, A Pergami, et al.Pageof 19